News & Publications for:

Joel Perlmutter

In Vivo Characterization of Two 18F-Labeled PDE10A PET Radioligands in Nonhuman Primate Brains

Posted on June 1, 2018

Hui Liu, Hongjun Jin, Zonghua Luo, Xuyi Yue, Xiang Zhang, Hubert Flores, Yi Su, Joel S. Perlmutter, and Zhude Tu. ACS Chemical Neuroscience, Volume 9, Issue 5, 16 May 2018, Pages 1066-1073 Read More

Posted in: HPAN, Neurodegeneration, Publications Faculty:

Physical therapy and deep brain stimulation in Parkinson’s Disease: Protocol for a pilot randomized controlled trial

Posted on May 25, 2018

Ryan P. Duncan, Linda R. Van Dillen, Jane M. Garbutt, Gammon M. Earhart and Joel S. Perlmutter. Pilot and Feasibility Studies, Volume 4, Issue 1, 25 April 2018, Article number 54 Read More

Posted in: HPAN, Neurodegeneration, Publications Faculty:

Pleiotropic effects of variants in dementia genes in Parkinson disease

Posted on April 27, 2018

Laura Ibanez, Umber Dube, Albert A. Davis, Maria V. Fernandez, John Budde, Breanna Cooper, Monica Diez-Fairen, Sara Ortega-Cubero, Pau Pastor, Joel S. Perlmutter, Carlos Cruchaga, and Bruno A. Benitez. Frontiers in Neuroscience, Volume 12, Issue APR, 10 April 2018, Article number 230 Read More

Posted in: News Faculty: ,

Factors Associated With End-of-Life Planning in Huntington Disease

Posted on February 23, 2018

Downing, et al. American Journal of Hospice and Palliative Medicine, Volume 35, Issue 3, 1 March 2018, Pages 440-447 Read More

Posted in: HPAN, Neurodegeneration, Publications Faculty:

7T MRI subthalamic nucleus atlas for use with 3T MRI

Posted on January 26, 2018

Mikhail Milchenko, Scott A. Norris, Kathleen L. Poston Meghan C. Campbell Mwiza Ushe Joel S. Perlmutter Abraham Z. Snyder. Journal of Medical Imaging, Volume 5, Issue 1, January-March 2018, Article number 015002 Read More

Posted in: HPAN, Neurodegeneration, Publications Faculty: